Thermo Fisher Scientific Launches TrueMark STI Select Panel
Posted: 9 February 2023 Research Panel Detects Four of the Most Common Sexually Transmitted Infectious Pathogens with One Panel Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems TrueMark STI…
Successful Completion of Planned DSMB Review of ACTION3 FSGS Kidney Trial
Posted: 9 February 2023 Dimerix Limited a biopharmaceutical company with late-stage clinical assets in inflammatory diseases, today confirmed that an independent Data Safety Monitoring Board (DSMB) has successfully concluded a review of the ACTION3 phase 3 clinical trial.…
Positive Results for SubB2M Breast Cancer Test
Posted: 9 February 2023 INOVIQ Limited is pleased to announce positive results from an independent retrospective case-control study to evaluate the performance of its SubB2M-CA15.3 breast cancer test across all stages of breast cancer. CA15.3 is a tumour…
Brain cancer research unlocks fundamental understanding of tumour cell behaviour
Posted: 7 February 2023 A cancer research team, led by Doherty Institute Associate Professor Theo Mantamadiotis, Head of the Brain Cancer Molecular Biology Lab at the University of Melbourne, is working to decipher the molecular and cellular mechanisms…
Student Scholarship and Volunteering Opportunities
Posted: 7 February 2023 Closes: 28 April, 5pm (if places are not filled earlier). ARCS Australia is offering a careers day on Thursday 8 June as part of the 2023 ARCS Annual Conference. The conference is widely regarded as…
Immutep Reaches Enrolment Target for INSIGHT-003 Trial in 1st Line NSCLC
Posted: 7 February 2023 Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune diseases, today announces the investigator-initiated INSIGHT-003 trial has reached its enrolment target of 20 patients with 1L NSCLC. INSIGHT-003 is…
Positive independent review sets priority path to market for MagSense Technology
Posted: 7 February 2023 Imagion Biosystems Limited, a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce that an independent blinded review by a panel of expert breast cancer radiologists has corroborated…
Optiscan Accelerating Momentum in 2023 with Refreshed Branding, New Team and Exciting AI Development
Posted: 6 February 2023 Optiscan Imaging this week announced an exclusive collaboration with Canadian based Prolucid Technologies to develop Artificial Intelligence (AI) algorithms and telepathology workflows using its confocal laser endomicroscopy (CLE) technology. The project, anticipated to take…
Alterity’s ATH434 Prevents Loss of Brain Cells in Parkinson’s Disease Animal Model
Posted: 31 January 2023 Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that a study recently published in the journal Neurotherapeutics demonstrated that its lead clinical asset, ATH434, was neuroprotective in…
MedTech Innovator Asia Pacific 2023 Program
Posted: 31 January 2023 Closes: 15 February 2023 About MedTech Innovator MedTech Innovator is the largest and highest performing accelerator of medical technology in the world and the medtech industry’s premiere showcase and competition for innovative medical device,…
$3.0m CRC-P grant to VivaZome Therapeutics and Partners for Customised Exosome Therapy
Posted: 24 January VivaZome Therapeutics Pty Ltd is delighted to announce that it has been awarded an Australian Government Round 13 CRC-P grant of $3.0m in support of the project “Customised exosomes – the future of regenerative medicine”.…
Adherium has commenced production and market release of the new, next generation Ellipta sensor
Posted: 23 January Adherium Limited, a leader in respiratory eHealth, remote patient monitoring and data management solutions, is pleased to announce that it has commenced production and market release of the new, next generation Hailie sensors with physiological…
